506
Participants
Start Date
February 29, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
August 31, 2013
Deoxycholic acid injection
Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.
Placebo
Phosphate buffered saline placebo for injection
Investigational Site, New York
Investigational Site, New York
Investigational Site, Washington D.C.
Investigational Site, Glenn Dale
Investigational Site, Rockville
Investigational Site, Hunt Valley
Investigational Site, Charlottesville
Investigational Site, Charlotte
Investigational Site, Snellville
Investigational Site, Atlanta
Investigational Site, Miami Beach
Investigational Site, West Palm Beach
Investigational Site, Birmingham
Investigational Site, Nashville
Investigational Site, Nashville
Investigational Site, Louisville
Investigational Site, Evansville
Investigational Site, West Bloomfield
Investigational Site, Fridley
Investigational Site, Arlington
Investigational Site, Chicago
Investigational Site, Omaha
Investigational Site, Los Angeles
Investigational Site, Beverly Hills
Investigational Site, Beverly Hills
Investigational Site, Oceanside
Investigational Site, San Diego
Investigational Site, San Diego
Investigational Site, Irvine
Investigational Site, Spokane
Investigational Site, New Haven
Investigational Site, Peterborough
Investigational Site, Toronto
Investigational Site, Toronto
Investigational Site, Montreal
Investigational Site, Vancouver, B.C.
Lead Sponsor
Kythera Biopharmaceuticals
INDUSTRY